Comparison of therapeutic antibiotic treatments on tissue-engineered human skin substitutes

Tissue Engineering - Part A.

Volumn 14, Issue 5, 2008, Pages 629-638

  Gibson, Angela L ^a   Schurr, Michael J ^a,c   Schlosser, Sandy J ^a   Comer, Allen R ^b   Allen Hoffmann, B Lynn ^a,b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Stratatech Corporation   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG THERAPY; GRAFTS; PROSTHETICS; SKIN; TISSUE ENGINEERING;

HUMAN SKIN SUBSTITUTES; KERATINOCYTE CELL LINE; SKIN GRAFTS; TISSUE MORPHOLOGY;

ANTIBIOTICS;

CASPASE 3; GLYCOGEN; MAFENIDE; MAFENIDE ACETATE; NEOMYCIN; NEOSPORIN; POLYMYXIN;

ANTIBIOTIC THERAPY; ARTICLE; BIOENGINEERING; CELL DEGENERATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; SKIN; SKIN GRAFT; TISSUE ENGINEERING; TISSUE STRUCTURE;

EID: 43649105397     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/tea.2007.0126     Document Type: Article

References (37)

1. Naughton, G.K. From lab bench to market: critical issues in tissue engineering. Ann NY Acad Sci 961, 372-385, 2002.
2. MacNeil, S. Progress and opportunities for tissue-engineered skin. Nature 445(7130), 874-880, 2007.
3. Kaur, P. Interfollicular epidermal stem cells: identification, challenges, potential. J Invest Dermatol 126(7), 1450-1458, 2006.
4. Cotsarelis, G. Epithelial stem cells: a folliculocentric view. J Invest Dermatol 126(7), 1459-1468, 2006.
5. Allen-Hoffmann, B.L., Schlosser, S.J., Ivarie, C.A., Sattler, C.A., Meisner, L.F., and O'Connor, S.L. Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J Invest Dermatol 114(3), 444-455, 2000.
6. Broughton, G., 2nd, Janis, J.E., and Attinger, C.E. Wound healing: an overview. Plast Reconstr Surg Jun; 117(7), 1e-S-32e-S, 2006.
7. Kucan, J.O., and Heggers, J.P. The potential benefit of 5% sulfamylon solution in the treatment of acinetobacter baumannii-contaminated traumatic war wounds. J Burn Wounds 4, e3, 2005.
8. Wilson, M.A. Skin and soft-tissue infections: impact of resistant gram-positive bacteria. Am J Surg 186(5), 35S-41S, 2003; discussion 42S-43S, 61S-64S.
9. Miller, S.F., Bessey, P.Q., Schurr, M.J., Browning, S.M., Jeng, J.C., Caruso, D.M., Gomez, M., Latenser, B.A., Lentz, C.W., Saffle, J.R., Kagan, R.J., Purdue, G.F., and Krichbaum, J.A. National burn repository 2005: a ten-year review. J Burn Care Res 27(4), 411-436, 2006.
10. Herndon, D.N., Barrow, R.E., Rutan, R.L., Rutan, T.C., Desai, M.H., and Abston, S. A comparison of conservative versus early excision. Therapies in severely burned patients. Ann Surg 209(5), 547-552, 1989; discussion 552-553.
11. Sheridan, R.L., and Tompkins, R.G. Skin substitutes in burns. Burns 25(2), 97-103, 1999.
12. Holder, I.A., and Neely, A.N. Does the addition of nystatin to 5% mafenide acetate and genitourinary irrigant solutions interfere with their antimicrobial activity? assessment by two topical antimicrobial test assay systems. J Burn Care Rehabil 22(4), 282-287, 2001.
13. Church, D., Elsayed, S., Reid, O., Winston, B., and Lindsay, R. Burn wound infections. Clin Microbiol Rev 19(2), 403-434, 2006.
14. Allen-Hoffmann, B.L., and Rheinwald, J.G. Polycyclic aromatic hydrocarbon mutagenesis of human epidermal keratinocytes in culture. Proc Natl Acad Sci USA 81(24), 7802-7806, 1984.
15. Watt, F.M. Influence of cell shape and adhesiveness on stratification and terminal differentiation of human keratinocytes in culture. J Cell Sci Suppl 8, 313-326, 1987.
16. Lobitz, W.C., Jr., and Holyoke, J.B. The histochemical response of the human epidermis to controlled injury; glycogen. J Invest Dermatol 22(3), 189-198, 1954.
17. Fleming, K.A., and McGee, J.O. Alcohol induced liver disease. J Clin Pathol 37(7), 721-733, 1984.
18. Montagna, W., Chase, H.B., and Lobitz, W.C., Jr. Histology and cytochemistry of human skin. II. The distribution of glycogen in the epidermis, hair follicles, sebaceous glands and eccrine sweat glands. Anat Rec 114(2), 231-247, 1952.
19. Doseff, A.I. Apoptosis: the sculptor of development. Stem Cells Dev 13(5), 473-483, 2004.
20. Gallico, G.G., 3rd, O'Connor, N.E., Compton, C.C., Kehinde, O., and Green, H. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 311(7), 448-451, 1984.
21. McCauley, R.L., Li, Y.Y., Poole, B., Evans, M.J., Robson, M.C., Heggers, J.P., and Herndon, D.N. Differential inhibition of human basal keratinocyte growth to silver sulfadiazine and mafenide acetate. J Surg Res 52(3), 276-285, 1992.
22. Cooper, M.L., Laxer, J.A., and Hansbrough, J.F. The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. J Trauma 31(6), 775-782, 1991; discussion 782-784.
23. Bennett, L.L., Rosenblum, R.S., Perlov, C., Davidson, J.M., Barton, R.M., and Nanney, L.B. An in vivo comparison of topical agents on wound repair. Plast Reconstr Surg 108(3), 675-687, 2001.
24. Smoot, E.C., 3rd, Kucan, J.O., Roth, A., Mody, N., and Debs, N. In vitro toxicity testing for antibacterials against human keratinocytes. Plast Reconstr Surg 87(5), 917-924, 1991.
25. Syrjanen, S., Mikola, H., Nykanen, M., and Hukkanen, V. In vitro establishment of lytic and nonproductive infection by herpes simplex virus type 1 in three-dimensional keratinocyte culture. J Virol 70(9), 6524-6528, 1996.
26. Shelley, W.B., and Arthur, R.P. The physiology of the skin. Annu Rev Physiol 20, 179-206, 1958.
27. Eagon, R.G., and McManus, A.T. The effect of mafenide on dihydropteroate synthase. J Antimicrob Chemother 25(1), 25-29, 1990.
28. Roujeau, J.C., and Stern, R.S. Severe adverse cutaneous reactions to drugs. N Engl J Med 331(19), 1272-1285, 1994.
29. Reilly, T.P., and Ju, C. Mechanistic perspectives on sulfonamide- induced cutaneous drug reactions. Curr Opin Allergy Clin Immunol 2(4), 307-315, 2002.
30. Roychowdhury, S., Vyas, P.M., Reilly, T.P., Gaspari, A.A., and Svensson, C.K. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drugprotein adducts in human epidermal keratinocytes. J Pharmacol Exp Ther 314(1), 43-52, 2005.
31. Boyce, S.T., Supp, A.P., Swope, V.B., and Warden, G.D. Topical sulfamylon reduces engraftment of cultured skin substitutes on athymic mice. J Burn Care Rehabil 20(1), 33-36, 1999.
32. Sachsenmeier, K.F., Sheibani, N., Schlosser, S.J., and Allen- Hoffmann, B.L. Transforming growth factor-beta 1 inhibits nucleosomal fragmentation in human keratinocytes following loss of adhesion. J Biol Chem 271(1), 5-8, 1996.
33. Gniadecki, R., Jemec, G.B., Thomsen, B.M., and Hansen, M. Relationship between keratinocyte adhesion and death: anoikis in acantholytic diseases. Arch Dermatol Res 290(10), 528-532, 1998.
34. Carroll, D.K., Carroll, J.S., Leong, C.O., Cheng, F., Brown, M., Mills, A.A., Brugge, J.S., and Ellisen, L.W. p63 regulates an adhesion programme and cell survival in epithelial cells. Nat Cell Biol 8(6), 551-561, 2006.
35. Marconi, A., Dallaglio, K., Lotti, R., Vaschieri, C., Truzzi, F., Fantini, F., and Pincelli, C. Survivin identifies keratinocyte stem cells and is downregulated by anti-beta1 integrin during anoikis. Stem Cells 25(1), 149-155, 2007.
36. Thrash, B.R., Menges, C.W., Pierce, R.H., and McCance, D.J. AKT1 provides an essential survival signal required for differentiation and stratification of primary human keratinocytes. J Biol Chem 281(17), 12155-12162, 2006.
37. Brown, T.P., Cancio, L.C., McManus, A.T., and Mason, A.D., Jr. Survival benefit conferred by topical antimicrobial preparations in burn patients: a historical perspective. J Trauma 56(4), 863-866, 2004.